Skip to main content
. 2021 Jun 22;2021:6639366. doi: 10.1155/2021/6639366

Table 2.

Association between tumor types and HPD for Immunotherapy-treated patients.

Tumor types Non-HPD (n = 339) HPD (n = 38) The incidence of HPD P
 Lung cancer 119 14 10.53%
 Pancreatic cancer 18 7 28.00%
 Esophageal cancer 8 2 20.00%
 Colorectal cancer 17 5 22.73%
 Cholangiocarcinoma 19 3 13.64%
 Liver cancer 15 2 11.76% <0.01
 Lymphoma 25 1 3.85%
 Ampullary carcinoma 5 1 16.67%
 Cervical carcinoma 6 1 14.29%
 Gastric carcinoma 31 2 6.06%
 Other 76 0 0.00%

HPD: hyperprogressive disease.